Clinic
Washoe Barton Medical Clinic a Nevada Nonprofit Corporation
Washoe Barton Medical Clinic a Nevada Nonprofit Corporation was paid $3.23M by Medicaid between Jan 2018 and Dec 2024, across 128 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.
33Billing provider infoWASHOE BARTON MEDICAL CLINIC A NEVADA NONPROFIT CORPORATION
GARDNERVILLE, NV 89410
GARDNERVILLE, NV 89410
33aNPI1396799102assigned 05/19/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.23M
24GClaims214,800
24DCodes billed128
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Nevada
Rank by total paid#7 of 53
Median peer was paid$521K
This provider vs. median6.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,543 | $398K | |
| 2019 | 37,191 | $458K | |
| 2020 | 25,196 | $374K | |
| 2021 | 30,926 | $517K | |
| 2022 | 33,208 | $555K | |
| 2023 | 34,896 | $509K | |
| 2024incomplete | 22,840 | $421K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 5,850 | 4,264 | $585K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 5,570 | 3,400 | $538K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 7,133 | 6,008 | $456K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12% | 8,701 | 2,433 | $375K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11% | 1,623 | 1,178 | $359K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.0% | 3,544 | 3,017 | $129K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 1,414 | 1,079 | $102K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.8% | 5,538 | 4,836 | $89K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.7% | 6,992 | 2,028 | $86K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.9% | 736 | 695 | $62K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.6% | 2,296 | 1,413 | $53K |
| 0450 | Emergency room services | 1.6% | 914 | 812 | $51K |
116 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 15,481 | $42K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 904 | $28K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,946 | $27K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,533 | $26K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 847 | $20K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,805 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,321 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,040 | $14K |
| G0378 | Hospital observation service, per hour | <1% | 67 | $12K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 867 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,628 | $10K |
| 80050 | General health panel | <1% | 209 | $10K |
| 97162 | <1% | 172 | $9K | |
| 99199 | Unlisted special service, procedure or report | <1% | 189 | $9K |
| 80061 | Lipid panel | <1% | 4,557 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,387 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,698 | $6K |
| 82607 | <1% | 495 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,155 | $6K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 24 | $6K |
| 87186 | <1% | 973 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,113 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,199 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 241 | $4K |
| 97161 | <1% | 93 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 280 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 20 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,051 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,219 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 15 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 61 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,832 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 533 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $1K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 747 | $1K |
| 81025 | <1% | 1,127 | $1K | |
| 84484 | <1% | 3,525 | $1K | |
| 83690 | <1% | 3,433 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,374 | $961.21 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 63 | $945.55 |
| 71045 | Radiologic examination, chest; single view | <1% | 2,381 | $785.44 |
| 0250 | <1% | 285 | $781.83 | |
| 80306 | <1% | 146 | $766.12 | |
| 85610 | <1% | 2,173 | $682.59 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,708 | $682.06 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 63 | $607.20 |
| 82728 | <1% | 94 | $580.83 | |
| 81003 | <1% | 5,430 | $514.79 | |
| 83880 | <1% | 238 | $504.30 | |
| 85027 | <1% | 1,783 | $489.84 | |
| 84481 | <1% | 39 | $460.13 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,889 | $437.47 |
| 73630 | <1% | 44 | $374.56 | |
| 87077 | <1% | 1,129 | $360.64 | |
| 83605 | <1% | 1,147 | $341.48 | |
| 85730 | <1% | 526 | $341.32 | |
| 87400 | <1% | 992 | $338.22 | |
| 84439 | <1% | 2,834 | $268.17 | |
| 87070 | <1% | 198 | $260.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,763 | $244.48 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 73 | $230.44 |
| 84153 | <1% | 81 | $225.98 | |
| 72100 | <1% | 13 | $215.85 | |
| 83735 | <1% | 2,511 | $212.48 | |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 5,066 | $207.79 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 501 | $193.10 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $192.02 |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,484 | $191.17 |
| 87040 | <1% | 234 | $166.53 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $151.19 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,789 | $140.39 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 214 | $137.54 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,395 | $135.85 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 706 | $135.35 |
| 86140 | <1% | 812 | $130.30 | |
| 86803 | <1% | 91 | $125.25 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 956 | $110.27 |
| 87430 | <1% | 273 | $96.02 | |
| 80305 | <1% | 45 | $93.56 | |
| 73130 | <1% | 17 | $78.30 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 384 | $65.98 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,351 | $60.81 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 218 | $58.98 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 611 | $56.52 |
| 82570 | <1% | 205 | $53.29 | |
| 96376 | <1% | 287 | $51.04 | |
| 86703 | <1% | 31 | $33.78 | |
| 85651 | <1% | 615 | $26.80 | |
| 80076 | <1% | 36 | $25.86 | |
| 86038 | <1% | 39 | $24.55 | |
| 84702 | <1% | 31 | $21.83 | |
| 97014 | <1% | 271 | $14.18 | |
| 82746 | <1% | 14 | $10.03 | |
| 85379 | <1% | 50 | $6.95 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,116 | $6.86 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 15 | $5.96 |
| 85652 | <1% | 268 | $4.72 | |
| A9270 | Non-covered item or service | <1% | 3,130 | $1.43 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 61 | $0.88 |
| 94760 | 0% | 105 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 347 | $0.00 |
| 83550 | 0% | 206 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 14 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 101 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 54 | $0.00 |
| 87205 | 0% | 15 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | $0.00 |
| 83540 | 0% | 276 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 67 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 48 | $0.00 |
| 96367 | 0% | 13 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 37 | $0.00 |
| 90662 | 0% | 12 | $0.00 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 24 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 13 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRATER, JEFFREY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Washoe Barton Medical Clinic a Nevada Nonprofit Corporation | Minden, NV | $2.25M |
| Washoe Barton Medical Clinic a Nevada Nonprofit Corporation | Wellington, NV | $366K |
| Carson Valley Health Rural Health Clinic | Gardnerville, NV | $120K |
| Washoe Barton Medical Clinic a Nevada Nonprofit Corporation | Gardnerville, NV | $6K |
| Granite County Hospital District | Philipsburg, MT | $920.67 |
| Granite County Hospital District | Drummond, MT | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.